Pulmonology
Pulmonary Edema
Fluid in the alveoli — cardiogenic backpressure vs ARDS capillary leak
Pulmonary edema is fluid accumulating in alveoli, impairing gas exchange. Cardiogenic edema arises from raised left atrial pressure (PCWP >18 mmHg). Non-cardiogenic edema is ARDS — inflammatory capillary leak. Pink frothy sputum, bilateral crackles, white-out on CXR.
- Cardiogenic thresholdPCWP > 18 mmHg
- Top triggerAcute LV failure / hypertensive crisis
- Non-cardiogenic exemplarARDS (Berlin definition)
- Diagnostic biomarkerBNP > 400 pg/mL supports cardiogenic
- First-line NIVCPAP / BiPAP — reduces intubation
- ARDS mortality30-45% (moderate-severe)
Interactive visualization
Press play, or step through manually. The visualization is yours to drive — try it before reading on.
Watch the 60-second explainer
A condensed visual walkthrough — narrated, captioned, under a minute.
Starling forces and the failing heart
Every capillary in the body is the site of a tug-of-war between hydrostatic pressure (pushing fluid out) and oncotic pressure (pulling it back in). The Starling equation describes the balance. In the systemic circulation, mean capillary pressure (~25 mmHg) modestly exceeds plasma oncotic pressure (~22 mmHg), and a small net outflow is collected by lymphatics. In the pulmonary circulation the math is the same but the numbers are lower — capillary hydrostatic pressure ~7-10 mmHg, oncotic ~22 mmHg — so the pulmonary capillary is a place where fluid is gently absorbed, with lymphatic drainage taking the rest. The alveolus stays dry.
Now raise the left atrial pressure. The mitral valve no longer holds back the column of blood draining from the lungs — pressure backs up through the pulmonary veins, into the pulmonary capillaries, raising their hydrostatic pressure. At a wedge pressure (PCWP, the bedside surrogate for left atrial pressure) of ~18 mmHg, lymphatic drainage is overwhelmed and fluid begins to fill the interstitium. At ~25 mmHg, fluid spills into the alveolus itself. The patient becomes acutely dyspneic, hypoxic, and pink-frothy. Reverse the pressure (with diuretics, vasodilators, and CPAP) and the process literally reverses — fluid moves back the way it came.
ARDS — a different kind of leak
In ARDS the membrane itself is broken. Inflammatory mediators released in sepsis, pneumonia, aspiration, pancreatitis, or major trauma damage the alveolar-capillary barrier. The endothelial junctions open. The type I pneumocytes that line the alveolar surface are injured. Protein-rich exudate floods the alveolus through what is now a permeable, not just over-pressured, membrane. Hyaline membranes form. Surfactant is destroyed. Some alveoli fill with fluid; others collapse from atelectasis; the result is severe V/Q mismatch and shunt physiology that resists supplemental oxygen.
The defining feature is that pressure is not the culprit. A patient in ARDS can have a normal or even low wedge pressure and still have severe edema — because the fluid is leaking through damaged membrane, not being squeezed through intact membrane. This is why diuretics, the workhorse of cardiogenic edema, are not the answer in ARDS. Treatment of ARDS is the source of the inflammation (sepsis, pneumonia) and protective lung ventilation while the membrane heals.
Worked clinical example
A 71-year-old woman with known HFrEF (EF 28%) presents at 3 AM unable to lie flat, gasping. Husband reports she had a salty meal last night and missed her evening furosemide. Vitals: HR 122, BP 198/108, RR 32, SpO₂ 84% on 6 L NC, T 36.9. Examination: speaking in 3-word phrases, sitting forward, diaphoretic, bilateral crackles audible at lung apices, S3 gallop, JVP 10 cm. Pink-tinged frothy sputum at the mouth. ECG: sinus tachycardia, LVH, no acute ST changes. BNP 1840 pg/mL. Troponin mildly elevated (demand). CXR: cardiomegaly, bilateral perihilar 'bat-wing' alveolar edema with Kerley B lines and small bilateral pleural effusions.
Diagnosis: acute decompensated heart failure with cardiogenic pulmonary edema, triggered by dietary indiscretion and missed dose, on a background of HFrEF. Treatment in the first 15 minutes: sit upright, NIV (BiPAP 12/5), nitroglycerin sublingual then infusion (starting 10 mcg/min, titrate to SBP <160), furosemide 80 mg IV (twice her home dose). Within 30 minutes she has urinated 800 mL, BP fallen to 152/88, RR 24, SpO₂ 94% on 50% via BiPAP. Within 2 hours she is comfortable on 4 L nasal cannula, transferred to telemetry rather than ICU. Day 2: switched back to oral furosemide, increased lisinopril, intensive HF education on salt and adherence. Discharged day 4 with a heart-failure clinic appointment in 7 days.
Cardiogenic vs non-cardiogenic edema
| Feature | Cardiogenic (CPE) | Non-cardiogenic (ARDS) |
|---|---|---|
| Mechanism | Raised hydrostatic pressure; intact membrane | Inflammatory membrane injury; protein-rich leak |
| PCWP | > 18 mmHg | < 18 mmHg (often normal) |
| Edema fluid protein:serum ratio | < 0.5 (transudate) | > 0.5 (exudate) |
| BNP | Often > 400 pg/mL | Normal or mildly elevated |
| CXR distribution | Central, perihilar 'bat-wing'; cardiomegaly | Peripheral, patchy; normal heart size |
| Pleural effusions | Common (often bilateral) | Uncommon |
| Typical triggers | MI, HTN emergency, valve dz, volume overload | Sepsis, pneumonia, aspiration, TRALI, pancreatitis |
| First-line treatment | Sit up + O₂ + NIV + nitrate + loop diuretic | Treat cause + lung-protective ventilation + prone position |
Why pulmonary edema matters
- ED volume. Acute decompensated heart failure with pulmonary edema is one of the most common adult ED chief complaints; outcomes depend on speed of recognition.
- NIV — the intubation-sparer. Early CPAP/BiPAP halves the intubation rate in acute cardiogenic edema; the cheapest most effective intervention in acute care.
- ICU mortality. ARDS still carries 30-45% mortality; lung-protective ventilation and prone positioning are the two interventions with clear mortality benefit.
- Heart-failure readmission. Cardiogenic pulmonary edema admissions identify patients at high readmission risk — intensive transitional care helps.
- Bedside ultrasound. B-lines on lung ultrasound diagnose interstitial fluid faster and more sensitively than CXR; rapidly becoming standard of care.
- Transfusion-related ALI. TRALI is an under-recognized non-cardiogenic edema cause; blood-bank algorithms try to prevent it.
- High-altitude medicine. HAPE is a distinct hypoxic pulmonary vasoconstriction-driven edema, treated with descent, nifedipine, and oxygen.
Common misconceptions
- "All bilateral lung opacities are pneumonia." Bilateral, symmetric, central distribution with cardiomegaly is cardiogenic edema until proved otherwise.
- "Diuretics fix all pulmonary edema." They do not help ARDS — the leak is membrane-driven, not pressure-driven.
- "Morphine improves the dyspnea of pulmonary edema." Older teaching; current guidelines discourage routine morphine because of higher intubation and mortality rates.
- "Normal BNP rules out heart failure." BNP can be falsely low in obesity and acute flash pulmonary edema; clinical context matters.
- "NIV is contraindicated in altered mental status." Relative — if the cause of altered mental status is hypercapnia from edema, NIV often rescues it; close monitoring required.
- "Furosemide is dose-the-same-as-yesterday." Acute decompensation requires higher dose (2.5× home dose is a common rule) for adequate response.
Frequently asked questions
How does fluid actually get into the alveolus?
The Starling equation governs net fluid movement across the capillary wall. Forces pushing fluid out: capillary hydrostatic pressure and interstitial oncotic pressure. Forces pulling fluid in: plasma oncotic pressure (from albumin) and interstitial hydrostatic pressure. The capillary endothelium and alveolar epithelium normally form a tight semipermeable barrier; lymphatic drainage clears the small amounts of fluid that leak. In cardiogenic edema, raised left atrial pressure (PCWP >18 mmHg) raises capillary hydrostatic pressure, overwhelming lymphatic capacity and pushing transudate into the interstitium first, then the alveolus. In ARDS, the endothelium and epithelium themselves are damaged — junctions open, and protein-rich exudate (transudate edema fluid protein/serum ratio <0.5; exudate >0.5) leaks through.
What distinguishes cardiogenic from non-cardiogenic edema?
Mechanism, clinical context, and labs. Cardiogenic edema: history of heart failure, MI, valvular disease, hypertensive emergency, or volume overload. Elevated BNP (typically >400 pg/mL), elevated troponin in coronary cases, S3 gallop, distended neck veins, dependent peripheral edema, cardiomegaly on CXR, redistribution of pulmonary vascular markings, Kerley B lines. Non-cardiogenic (ARDS): pneumonia, sepsis, aspiration, transfusion, trauma, pancreatitis, drug overdose, or COVID-19. Normal-sized heart, no S3, BNP often normal or mildly elevated, edema fluid protein-rich, the Berlin definition (acute onset within 7 days, bilateral infiltrates, no cardiac cause, PaO₂/FiO₂ ratios). Bedside ultrasound is increasingly used — both produce 'B-lines' (comet-tail artifacts) on lung ultrasound, but cardiac ultrasound differentiates LV dysfunction from preserved function with bilateral exudate.
Why pink frothy sputum?
Three components converge. First, the transudate fluid leaking into alveoli is mixed with air during respiratory effort, producing froth. Second, raised pulmonary capillary pressure damages capillaries enough to allow some red blood cells through, tingeing the foam pink. Third, the sheer volume of fluid in severe cardiogenic edema overflows the alveoli into the major airways, where the patient coughs it up. It is a sign of severe disease — flash pulmonary edema, often with hypertensive crisis or acute MI as the trigger. The patient is typically sitting upright (orthopnea), diaphoretic, and visibly distressed, with bilateral crackles audible across both lung fields.
How is acute cardiogenic pulmonary edema treated?
Sit the patient upright. Oxygen titrated to SpO₂ 94-96% (88-92% in COPD). Noninvasive ventilation (CPAP or BiPAP) is the workhorse — it reduces work of breathing, splints alveoli open, decreases preload and afterload, and reduces intubation rates. IV loop diuretic (furosemide 40 mg, or 1× home dose if chronically on furosemide) reduces preload over minutes via vasodilation, then over hours via diuresis. Sublingual or IV nitrate (if SBP >110) drops preload further. Treat the underlying trigger: MI (cath lab), severe HTN (IV antihypertensive), arrhythmia (rate or rhythm control). Avoid morphine in modern guidelines — it does not improve outcomes and may worsen them. Intubation if exhausted, severely hypercapnic, or hypotensive.
How is ARDS managed differently?
Treat the underlying cause (sepsis source control, drainage of pancreatic collection, drug withdrawal). Lung-protective ventilation: tidal volume 6 mL/kg ideal body weight, plateau pressure <30 cmH₂O, permissive hypercapnia, PEEP titrated upward. Prone positioning for ≥12 hours/day in moderate-severe ARDS (PaO₂/FiO₂ <150) — a mortality-reducing intervention. Conservative fluid management (FACTT trial). Neuromuscular blockade in selected severe cases (ACURASYS, with caveats). ECMO for refractory cases at experienced centers. Steroids in COVID-related ARDS and selected severe ARDS. Mortality is 30-45% in moderate-severe disease. Loop diuretics are not the primary therapy in ARDS — the issue is leaky capillaries, not high pressure.
What does 'white-out' on chest X-ray mean?
Severe diffuse alveolar filling with fluid produces near-uniform opacification of both lung fields. In milder cardiogenic edema there is a sequence on CXR: redistribution of vascular markings to upper zones (cephalization), Kerley B lines (interlobular septal thickening from interstitial edema), perihilar 'bat-wing' or 'butterfly' distribution, then frank alveolar edema with air bronchograms, then white-out. Cardiogenic edema typically retains some heart-border definition with central distribution; ARDS gives more peripheral, patchy distribution and often spares the heart border. Bedside ultrasound's B-line pattern is increasingly used as a faster, more sensitive bedside tool than CXR — sensitive enough that absence of B-lines effectively rules out interstitial fluid.
Can pulmonary edema cause cardiac arrest?
Yes — severe hypoxia, acidosis, and the work of breathing can decompensate any patient to arrest. The death trajectory in untreated flash pulmonary edema is rapid: progressive hypoxia → fatigue → hypercapnia and acidosis → bradycardia → PEA arrest. NIV and aggressive preload reduction reverse this if started early. In refractory cardiogenic shock (acute MI complicated by pump failure and edema), mechanical circulatory support — IABP, Impella, VA-ECMO — bridges to definitive treatment. The mortality of cardiogenic shock with pulmonary edema after MI remains 30-50% despite all modern therapy, making prevention (early reperfusion) the highest-value intervention.